Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Corporate Update Points to Profitability in 2022 and Beyond
In 2021, Delic’s investments and acquisitions allowed for an annualized revenue run-rate of over $9MMGoing into the new year, the company looks forward to opening additional ketamine infusion treatment clinics, growing them by 15 within the next 18 monthsDelic’s growth has been attributed to the strong demand for alternatives to current treatments for mental health conditionsIts management is confident that the foundations laid down so…